Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-03-20Clinical Trial Update: OptiZ: Real World Evidence Study
The OptiZ real-world evidence study sponsored by Closed Loop Medicine has been withdrawn. It concerns hypertension.
-
CLINICAL_TRIALS withdrawal · 2026-02-19Clinical Trial Update: Withings Devices Follow-up Study - Hypertension
The Withings Devices Follow-up Study for hypertension has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2026-02-12Clinical Trial Update: The Effectiveness of a Preoperative Blood Pressure Screening Program to Identify Undiagnosed Hypertension in Ambulatory Surgery Patients
A clinical trial (NCT03678207) evaluating a preoperative blood pressure screening program to identify undiagnosed hypertension in ambulatory…
-
CLINICAL_TRIALS withdrawal · 2025-12-30Clinical Trial Update: Gamification to Increase Mobility in the Hospital [NA]
The clinical trial NCT04300764 evaluating gamification to increase mobility in hospitalized patients has been withdrawn. The sponsor is the …
-
CLINICAL_TRIALS withdrawal · 2025-10-02Clinical Trial Update: MA-CEAL Community Health Ambassador Program [NA]
Boston Medical Center has withdrawn the MA-CEAL Community Health Ambassador Program trial (NCT07136402). The study targeted hypertension and…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2025-08-14Clinical Trial Update: DASH Diet Intervention for Systemic Hypertension in Adolescents [NA]
The clinical trial evaluating a DASH diet intervention for hypertension in adolescents has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-07-31Clinical Trial Update: EuroNetrod HTN OFF-Med Study of Renal Denervation With NetrodTM Six-electrode Radiofrequency RDN System [NA]
The EuroNetrod HTN OFF-Med study evaluating the Netrod six-electrode renal denervation system for uncontrolled hypertension has been withdra…
-
CLINICAL_TRIALS withdrawal · 2025-07-30Clinical Trial Update: Inhibiting GABA Transaminase to Relieve Obesity Induced Hyperinsulinemia and Insulin Resistance [Phase 2]
A Phase 2 trial evaluating a GABA transaminase inhibitor to relieve obesity-induced hyperinsulinemia and insulin resistance has been withdra…
-
CLINICAL_TRIALS withdrawal · 2025-06-13Clinical Trial Update: Chronotherapy in Children With Chronic Kidney Disease [NA]
The pediatric chronotherapy trial NCT05353335 investigating chronic kidney disease with hypertension has been withdrawn; no results were rep…
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: ANGIOTENSIN AGENTS AND REDUCTION OF THE PRESCRIPTION OF ANTIDEPRESSANT DRUGS: A RETROSPECTIVE COHORT STUDY USING REAL-WORLD DATA
A retrospective real-world study examined whether angiotensin agents (ACE inhibitors and ARBs) influence antidepressant prescribing. The tri…
-
CLINICAL_TRIALS withdrawal · 2025-05-14Clinical Trial Update: Renal Sympathetic Denervation Combined With Aorticorenal Ganglion Ablation for Treatment of Hypertension [NA]
A clinical trial evaluating renal sympathetic denervation combined with aorticorenal ganglion ablation for hypertension has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-04-25Clinical Trial Update: Team Based Equity Conscious Telemedicine Approach to Hypertension [NA]
The clinical trial NCT06424730 investigating a team-based equity-conscious telemedicine approach to hypertension has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-04-07Clinical Trial Update: EngageRx With Integrated Self-Measurement of Blood Pressure [NA]
A UCSF-sponsored clinical trial evaluating EngageRx with integrated self-measurement of blood pressure for hypertension has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-02-18Clinical Trial Update: Continual vs. Routine Home Blood Pressure Monitoring and Management in Diverse Community Practice: CHANGE-BP [NA]
The CHANGE-BP trial evaluating continual versus routine home blood pressure monitoring in diverse community practice has been withdrawn from…
-
CLINICAL_TRIALS withdrawal · 2025-02-06Clinical Trial Update: A Comprehensive Optical Blood Pressure Assessment Tool to Identify Cases of Unscreened Hypertension Across an Active Population in the U.S.
The clinical trial evaluating an optical blood pressure assessment tool to identify unscreened hypertension in an active U.S. population has…
-
CLINICAL_TRIALS withdrawal · 2024-12-03Clinical Trial Update: Personalised Electronic Record Supported Optimisation of Amlodipine for Patients With Hypertension [Phase 4]
A Phase 4 trial investigating a personalised electronic record-supported optimisation of amlodipine for hypertension has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-10-09Clinical Trial Update: The Clinical Impact of Diet on Medical Conditions Treated Within Bundled Payment Models: a Pilot Study [NA]
A pilot clinical trial evaluating the impact of diet on conditions treated under bundled payment models has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-08-01Clinical Trial Update: Reduced Volume of Inspiratory Resistance Training [NA]
The clinical trial investigating reduced volume of inspiratory resistance training for hypertension has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-07-25Clinical Trial Update: Cardiovascular Risk Reduction in Epilepsy [NA]
A UCLA-sponsored clinical trial on cardiovascular risk reduction in epilepsy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-06-12Clinical Trial Update: Integrated Telehealth After Stroke Care [NA]
The clinical trial on Integrated Telehealth After Stroke Care sponsored by Columbia University has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-05-10Clinical Trial Update: Investigating Salt Taste Threshold in Patients Being Investigated for Primary Hyperaldosteronism Before and After Treatment.
Clinical trial NCT04556279 investigating salt taste thresholds in patients with primary hyperaldosteronism before and after treatment has be…
-
CLINICAL_TRIALS withdrawal · 2023-09-08Clinical Trial Update: Efficacy and Safety of Atenas Association in the Treatment of Type II Diabetes Mellitus and Hypertension [Phase 3]
Phase 3 clinical trial of Atenas Association for Type II diabetes mellitus and hypertension was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2023-09-08Clinical Trial Update: Efficacy and Safety of Egito Association in the Treatment of Type II Diabetes Mellitus and Hypertension [Phase 3]
Phase 3 clinical trial investigating Egito Association for Type II diabetes mellitus and hypertension has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2023-05-06Clinical Trial Update: Sacubitril-valsartan Versus Usual Anti-hypertensives in LVAD [Phase 4]
A Phase 4 trial comparing sacubitril-valsartan to usual antihypertensives in patients with congestive heart failure and hypertension has bee…
-
CLINICAL_TRIALS withdrawal · 2023-03-20Clinical Trial Update: Effect of PRM-125 on Ambulatory Blood Pressure [Phase 3]
Phase 3 trial evaluating PRM-125 for ambulatory blood pressure was withdrawn.